Infectious Disease Testing Market in the US 2015-2019

Published: Jan 2016
Pages: 66
SKU: IRTNTR8448

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version!

About infectious disease testing

Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care.

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview
Top-vendor offerings

PART 03: Market research methodology

Research methodology
Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

PART 06: Infectious disease landscape in the US

Reimbursement in US
Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
Five forces analysis

PART 07: Market segmentation by technology

Molecular diagnostic test
POCT for infectious diseases
Immunodiagnostic tests

PART 08: Market segmentation by application

PART 09: Market segmentation by product

Equipment
Consumables

PART 10: Market drivers

NAFTA
Demand for rapid and automated diagnostics
Shift toward patient-centered model
Focus on disease management

PART 11: Impact of drivers

PART 12: Market challenges

Medical device excise tax law
Increase in globalization
New microbial diseases

PART 13: Impact of drivers and challenges

PART 14: Market trends

Development of innovative diagnostics initiatives
Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
Low-cost microfluidic devices for POCT
Focus on early diagnosis of infectious diseases

PART 15: Vendor landscape